1. Home
  2. SXC vs IRWD Comparison

SXC vs IRWD Comparison

Compare SXC & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$7.64

Market Cap

621.1M

Sector

Industrials

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.58

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXC
IRWD
Founded
1960
1998
Country
United States
United States
Employees
848
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
621.1M
663.6M
IPO Year
2011
2009

Fundamental Metrics

Financial Performance
Metric
SXC
IRWD
Price
$7.64
$3.58
Analyst Decision
Hold
Buy
Analyst Count
1
3
Target Price
$9.00
$7.67
AVG Volume (30 Days)
1.4M
2.2M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
7.17%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.24
Revenue
$1,600,300,000.00
$298,276,000.00
Revenue This Year
N/A
$57.95
Revenue Next Year
N/A
$4.39
P/E Ratio
N/A
$15.23
Revenue Growth
10.30
8.88
52 Week Low
$5.52
$0.55
52 Week High
$8.92
$5.78

Technical Indicators

Market Signals
Indicator
SXC
IRWD
Relative Strength Index (RSI) 68.97 39.56
Support Level $7.21 $3.07
Resistance Level $8.34 $3.92
Average True Range (ATR) 0.31 0.33
MACD 0.08 -0.11
Stochastic Oscillator 78.61 7.45

Price Performance

Historical Comparison
SXC
IRWD

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: